Lewis H. Titterton jr - 12 Jan 2024 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIX	Employee Stock Option (Right to Buy)	Award	$0	+25,000		$0.000000	25,000	12 Jan 2024	Common Stock	25,000	$4.39	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2	The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2024.